Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Amy Schumer lost 30 pounds using Ozempic, but experienced negative side effects. She was "bedridden" and didn't have energy. Amy has a gene that makes her "prone to nausea," which she believes is ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds. Now, a new study finds that Ozempic, along with similar drugs such ...

Here’s a chart of drugs that can interact with Ozempic. Keep in mind that this chart does not include all drugs that may interact with Ozempic. Some of these interactions are described in detail ...

Certain foods can mimic the effects of Ozempic, a weight loss drug, helping reduce hunger. Here's what worked for a woman during her weight loss journey. Aimee Meier has shared her list of foods ...

GLP-1 receptor agonist medications like Ozempic may do more than just change your waistline—they could influence how you shop at the grocery store. That’s the major takeaway from a new study ...

Amy Schumer is reflecting on her 'horrible' experience with Ozempic and why a certain 'gene' made it almost impossible for her to keep taking it. The comedian, 43, first started on the weight ...

Share on Pinterest The FDA approved Ozempic to help lower chronic kidney disease-related risks in people with type 2 diabetes. urbazon/Getty Images The Food and Drug Administration (FDA ...

Amy Schumer has recently spoken up about her horrific experience with Ozempic. The Trainwreck star recalled using weight-loss medication almost three years ago in 2022 but she stopped the once ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...